Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2014
10/14/2014US8859778 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
10/14/2014US8859775 Pyrazolopyridinone derivatives as LPA receptor antagonists
10/14/2014US8859747 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859745 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859615 Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
10/14/2014US8859595 Potent and selective inhibitors of hepatitis C virus
10/14/2014US8859593 Composition for improving cognition and memory
10/14/2014US8859584 TRPV1 antagonists
10/14/2014US8859574 Compounds and compositions as kinase inhibitors
10/14/2014US8859572 Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
10/14/2014US8859569 Substituted annellated pyrimidines and use thereof
10/14/2014US8859559 Substituted pyrazines and their use in the treatment of disease
10/14/2014US8859555 Lysine Specific Demethylase-1 inhibitors and their use
10/14/2014US8859551 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
10/14/2014US8859548 Compounds and compositions as protein kinase inhibitors
10/14/2014US8859544 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof
10/14/2014US8859542 Triazine compounds as PI3 kinase and mTOR inhibitors
10/14/2014US8859530 Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
10/14/2014US8859526 Methods for treating bleeding disorders using sulfated polysaccharides
10/14/2014US8859507 Protein complex for intracellular delivery and uses thereof
10/14/2014US8859502 Therapy for MLL-rearranged leukemia
10/14/2014US8859218 In situ detection of early stages and late stages HPV infection
10/14/2014US8859207 Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
10/14/2014US8858996 Pharmaceutical compositions for the coordinated delivery of NSAIDS
10/14/2014US8858995 Methods and compositions for controlled delivery of phytochemical agents
10/14/2014US8858994 Pharmaceutical formulation comprising ezetimibe
10/14/2014US8858982 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/14/2014US8858977 Drug delivery system
10/14/2014US8858964 Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
10/14/2014US8858952 Methods and materials for generating T cells
10/14/2014US8858942 Antibodies directed to ERBB2
10/14/2014US8858941 VEGF/DLL4 binding agents and uses thereof
10/14/2014US8858939 Ectopic pregnancy treatment
10/14/2014US8858927 Method for protection of peptides or proteins against non-enzymatic deamidation
10/14/2014US8858924 Compositions and methods for treatment of hemorrhage
10/14/2014US8858917 Methods for limiting spread of pulmonary infections
10/14/2014US8858912 Frozen compositions and methods for piercing a substrate
10/09/2014WO2014165482A1 Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment and management of central nervous system cancers
10/09/2014WO2014165412A2 Methods and compositions for treating cancers having acquired resistance to chemotherapeutic and targeted drugs using carboxyamidotriazole orotate
10/09/2014WO2014163142A1 Ophthalmic composition
10/09/2014WO2014161938A1 Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor
10/09/2014WO2014161595A1 Use of pidotimod to treat inflammatory bowel disease
10/09/2014WO2014161594A1 Use of pidotimod to treat irritable bowel syndrome
10/09/2014US20140303590 Method and composition for hyperthermally treating cells
10/09/2014US20140303257 Use of EDG Receptor Binding Agents in Cancer
10/09/2014US20140303251 Methods Of Treating Acute Kidney Injury With Retinoic Acid
10/09/2014US20140303247 Membrane activated chelators and use in the prevention and treatment of parasitic infection
10/09/2014US20140303242 Sparstolonin B Based Pharmaceutical Agent to Treat Pathological Angiogensis
10/09/2014US20140303234 Methods for the modulation of angiogenesis
10/09/2014US20140303231 Methods and compositions for treating or preventing pruritis
10/09/2014US20140303222 Dual-acting imidazole antihypertensive agents
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140303204 Modulators of cystic fibrosis transmembrane conductance regulator
10/09/2014US20140303201 Cancer therapy
10/09/2014US20140303191 Use of inhibitors of bruton's tyrosine kinase (btk)
10/09/2014US20140303190 Tyrosine kinase inhibitors
10/09/2014US20140303186 Nitrogen-containing fused ring compounds as crth2 antagonists
10/09/2014US20140303165 Heteroaryl compounds and uses thereof
10/09/2014US20140303164 Therapeutic compounds
10/09/2014US20140303161 Tyrosine kinase inhibitors
10/09/2014US20140303157 Metalloenzyme inhibitor compounds
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303127 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
10/09/2014US20140303126 Novel quinuclidine derivatives and medicinal compositions containing the same
10/09/2014US20140303124 Methods and compositions for the treatment of migraine headaches
10/09/2014US20140303120 Methods for the treatment of cancer
10/09/2014US20140303117 Method for Treating Acute Kidney Injury
10/09/2014US20140303101 Compositions for dental care
10/09/2014US20140303100 Compositions for dental care
10/09/2014US20140303099 Compositions and Methods for Improving Cardiovascular Health
10/09/2014US20140303092 Hexadecyloxypropyl cidofovir for the treatment of double-stranded dna virus infection
10/09/2014US20140303081 Apoptosis-targeting nanoparticles
10/09/2014US20140303074 Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription
10/09/2014US20140303070 Process for the manufacture of ajoene derivatives
10/09/2014US20140303069 Anti-Microbial Peptides and Methods of Use Thereof
10/09/2014US20140302175 Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease
10/09/2014US20140302170 Compositions and methods for promoting sleep
10/09/2014US20140302154 Magnetic transducers
10/09/2014US20140302153 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
10/09/2014US20140302148 Cannabinoid formulations
10/09/2014US20140302124 Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of INFLUENZA VIRUS INFECTION
10/09/2014US20140302123 Products useful for the treatment of malignant neoplasms of the human nervous system
10/09/2014US20140302058 Human anti il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases
10/09/2014US20140302053 Compositions for the treatment of rheumatoid arthritis and methods of using same
10/09/2014US20140302040 Novel Antibodies and Uses Thereof
10/09/2014US20140302036 Proteins specific for baff and b7rp1
10/09/2014US20140302023 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging
10/09/2014US20140302022 2-carboxamide clycloamino urea derivatives for use in treating vegf-dependent diseases
10/09/2014US20140302014 Methods for the treatment of cancer using coenzyme q10 combination therapies
10/09/2014US20140302010 Substituted benzimidazoles
10/09/2014US20140301999 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
10/09/2014US20140301994 Probiotic stick formulation for skin maintenance and methods of use
10/09/2014US20140301982 Complement antagonists and uses thereof
10/09/2014US20140301980 Methods for the treatment of psoriatic arthritis using apremilast
10/09/2014US20140301979 Anti-arenaviral compounds
10/09/2014US20140301978 Methods for using 1,2,4-oxadiazole benzoic acid compounds
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/09/2014US20140301975 Methods for Treating Blood Disorders
10/09/2014US20140301973 Combination therapies for treating type 1 diabetes
10/09/2014US20140301946 Antibody drug conjugates
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 1151